A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death

scientific article published on 01 June 1982

A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.1780250602
P698PubMed publication ID7046757

P50authorEllen M GinzlerQ91640182
P2093author name stringB H Hahn
T A Medsger
G Ziegler
N M Hadler
M Weiner
D A Albert
J H Klippel
M Schlesinger
E V Hess
J F Fries
E V Barnett
S Rosner
C Wasner
H S Diamond
A Grayzel
D Worth
G Spencer-Green
P433issue6
P921main subjectsystemic lupus erythematosusQ1485
P304page(s)612-617
P577publication date1982-06-01
P1433published inArthritis and RheumatismQ23929027
P1476titleA multicenter study of outcome in systemic lupus erythematosus. II. Causes of death
P478volume25

Reverse relations

cites work (P2860)
Q50988300"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.
Q48494584A case of diffuse lupus encephalopathy successfully treated with high-dose intravenous methylprednisolone
Q73635053Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy
Q50603809An epidemiologic analysis of end-stage lupus nephritis.
Q37765837Analysis of clinical manifestations and pathology of lupus nephritis: a retrospective review of 82 cases
Q35552703Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy
Q71691168Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study
Q40409570Aortic aneurysms in patients with autoimmune disorders treated with corticosteroids
Q71959681Aspergillosis in systemic lupus erythematosus
Q41260413Assessment of lupus: where are we now?
Q74198328Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus
Q34504806Atherosclerosis and connective tissue diseases
Q72155864Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate
Q34108825Circulating endothelial cells and vascular injury in systemic lupus erythematosus
Q33561226Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus
Q71103145Clinical features and outcome of infection in systemic lupus erythematosus
Q40154586Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases
Q35031666Concurrent presentation of cryptococcal meningoencephalitis and systemic lupus erythematosus
Q44081617Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients
Q37949332Current treatment recommendations for lupus nephritis
Q40919356Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients
Q36844749Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.
Q77746580Disseminated histoplasmosis in systemic lupus erythematosus: case report and review of the literature
Q73203789Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus
Q72315249Effect of bone marrow transplantation on antiphospholipid antibody syndrome in murine lupus mice
Q40868199End-stage renal disease in systemic lupus erythematosus
Q34072179Endothelial dysfunction in chronic inflammatory diseases
Q22299248Epidemiology and socioeconomic impact of skin disease in lupus erythematosus
Q44112212Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study
Q43532820Familial clustering of end-stage renal disease in blacks with lupus nephritis
Q90697238From Severe Herpes Zoster to Rare Suid Herpesvirus Encephalitis: A New Twist of the Varicellovirus Genus Infection in Patients with Kidney Diseases
Q74600355Infection in systemic lupus erythematosus
Q36691113Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review
Q71475036Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India
Q35084903Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis
Q34990100Infections in the immunocompromised rheumatologic patient
Q41475106Infectious complications of immunosuppressive therapy in patients with rheumatic diseases
Q74033013Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE)
Q37361762Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection
Q40440616Invasive aspergillosis in systemic lupus erythematosus
Q36683387Low socioeconomic status is associated with cardiovascular risk factors and outcomes in systemic lupus erythematosus
Q68492553Lupus Carditis
Q71984938Lupus Nephritis in Thailand: Clinicopathologic findings and outcome in 569 patients
Q40665188Lupus nephritis in childhood and adolescence
Q40742350Malignant histiocytosis as a fatal complication of systemic lupus erythematosus
Q36577423Mechanisms of disease: atherosclerosis in autoimmune diseases
Q50563149Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus.
Q35588087Mucormycosis in systemic lupus erythematosus
Q35552164Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus
Q39644827Neoplastic associations of rheumatic diseases and rheumatic manifestations of cancer.
Q40469520Neuropsychiatric Manifestations of Systemic Lupus Erythematosus
Q41377143Nocardiosis in systemic lupus erythematosus.
Q69791000Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus
Q33561735Outcome and survival in systemic lupus erythematosus
Q35551526Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades
Q33567599Outcome of patients with systemic rheumatic disease admitted to medical intensive care units
Q33448450Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort
Q73251573Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus
Q57704421Prevalence and significance of hypertension in systemic lupus erythematosus
Q77798512Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus
Q33286668Prognostic factors in systemic lupus erythematosus
Q43051274Prophylactic use of antibiotics and immunisations in patients with SLE.
Q35637257Raised serum S100B protein levels in neuropsychiatric lupus.
Q35626485Random spot urine protein/creatinine ratio: a reliable method for monitoring lupus nephritis?
Q35547805Renal haemodynamic characteristics in patients with lupus nephritis
Q49216020Risk of infection in hospitalised children with systemic lupus erythematosus: a 10-year follow-up
Q36307414Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study
Q42942667Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice
Q34564739Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus
Q50885213Survival analysis of 306 European Spanish patients with systemic lupus erythematosus.
Q47889345Survival of patients with SLE admitted to an intensive care unit-a retrospective study
Q71581580Systemic lupus erythematosus
Q43419630Systemic lupus erythematosus and cardiovascular disease
Q41523547Systemic lupus erythematosus and multiple myeloma: a rare association
Q39756290Systemic lupus erythematosus clinical issues
Q33357929Systemic lupus erythematosus in Tunisia. A multicentric study. About 295 cases
Q70287507Systemic lupus erythematosus in patients with chronic renal failure
Q68918938Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity
Q34034374Systemic lupus erythematosus in the elderly.
Q34990070Systemic lupus erythematosus in the intensive care unit
Q75828790Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity
Q33555951Systemic lupus erythematosus without clinical renal abnormalities: renal biopsy findings and clinical course
Q33562068Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively.
Q89835229The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis
Q67857724The actual survival rate in systemic lupus erythematosus: study of a 1976 cohort
Q33535433The heart in systemic lupus erythematosus
Q40179650The natural history of lupus erythematosus
Q34484053Why do patients with lupus nephritis die?
Q81772558[Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?]
Q84600749[Comorbidity of systemic lupus erythematosus]
Q69514089[Coronary trunk involvement in systemic lupus erythematosus. Possible role of corticotherapy. Apropos of a case]
Q84600784[Infections in the immunocompromised host. What is the role of the medications?]
Q77114590[Lupus nephropathy: implications of a long course]
Q40699216n-3 fatty acids and renal diseases

Search more.